IYUZEH Drug Patent Profile

✉ Email this page to a colleague

When do Iyuzeh patents expire, and what generic alternatives are available?

Iyuzeh is a drug marketed by Thea Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-seven countries.

The generic ingredient in IYUZEH is latanoprost. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Iyuzeh

A generic version of IYUZEH was approved as latanoprost by AMRING PHARMS on March 22^nd, 2011.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for IYUZEH?
What are the global sales for IYUZEH?
What is Average Wholesale Price for IYUZEH?

Summary for IYUZEH

International Patents:	34
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	79
Patent Applications:	6,239
Drug Prices:	Drug price information for IYUZEH
What excipients (inactive ingredients) are in IYUZEH?	IYUZEH excipients list
DailyMed Link:	IYUZEH at DailyMed

Drug patent expirations by year for IYUZEH

US Patents and Regulatory Information for IYUZEH

IYUZEH is protected by one US patents.

Patents protecting IYUZEH

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Thea Pharma	IYUZEH	latanoprost	SOLUTION/DROPS;OPHTHALMIC	216472-001	Dec 13, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for IYUZEH

See the table below for patents covering IYUZEH around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
San Marino	T201400098	Sistema di rilascio polimerico di una soluzione non viscosa a base prostaglandina senza conservante	⤷ Sign Up
South Korea	101809713		⤷ Sign Up
Japan	5877885		⤷ Sign Up
Japan	5657789		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for IYUZEH

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3461484	C202130024	Spain	⤷ Sign Up	PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107
0364417	97C0111	Belgium	⤷ Sign Up	PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071
3461484	SPC/GB21/033	United Kingdom	⤷ Sign Up	PRODUCT NAME: A COMBINATION OF LATANOPROST AND NETARSUDIL; REGISTERED: UK EU/1/20/1502(FOR NI) 20210107; UK PLGB 16053/0034 20210107
3461484	132021000000068	Italy	⤷ Sign Up	PRODUCT NAME: COMBINAZIONE DI LATANOPROST E NETARSUDIL(ROCLANDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1502, 20210108
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for IYUZEH

Patents protecting IYUZEH

Make Better Decisions: Try a trial or see plans & pricing